MA
RIGL icon

MUFG Americas’s Rigel Pharmaceuticals RIGL Stock Holding History

MUFG Americas’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-66
Closed -$2K – 1132
2017
Q3 		$2K Hold
66
– – ﹤0.01% 1052
2017
Q2 		$2K Hold
66
– – ﹤0.01% 1068
2017
Q1 		$2K Hold
66
– – ﹤0.01% 1063
2016
Q4 		$2K Sell
66
-67
-50% -$1.92K ﹤0.01% 1029
2016
Q3 		$5K Sell
133
-67
-34% -$1.92K ﹤0.01% 980
2016
Q2 		$4K Hold
200
– – ﹤0.01% 1043
2016
Q1 		$4K Sell
200
-137
-41% -$3.38K ﹤0.01% 996
2015
Q4 		$10K Buy
+337
New +$10.2K ﹤0.01% 836
2015
Q3 		– Sell
-111
Closed -$4K – 1235
2015
Q2 		$4K Buy
+111
New +$4.24K ﹤0.01% 1009

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

MUFG Americas's RIGL Position: Q4 2017 in Review

MUFG Americas sold out of Rigel Pharmaceuticals (RIGL) in Q4 2017, closing a stake of 66 shares — an estimated $2K sold.

MUFG Americas first reported a position in RIGL in Q2 2015 and held it in 9 quarters. The position peaked at $10K in Q4 2015. 121 funds tracked by Wall St. Rank hold RIGL as of Q4 2017.

  • MUFG Americas reported no remaining Rigel Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • MUFG Americas sold 66 Rigel Pharmaceuticals shares in Q4 2017, an estimated $2K.
  • MUFG Americas first reported a position in Rigel Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • MUFG Americas's Rigel Pharmaceuticals position peaked at $10K in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2017.

Based on MUFG Americas's 13F filing for Q4 2017, filed 8 Feb 2018.